Abstract:Metabolic syndrome (MTS) is a cluster of concurrent metabolic abnormal conditions. MTS and its component metabolic diseases are heterogeneous and closely related, making their relationships complicated, thus hindering precision treatment. Methods: We collected seven groups of samples (group a: healthy individuals; group b: obesity; group c: MTS; group d: hyperglycemia, group e: hypertension, group f: hyperlipidemia; group g: type II diabetes, n=7 for each group). We examined the molecular characteristics of each sample by metabolomic, proteomic and peptidomic profiling analysis. The differential molecules (including metabolites, proteins and peptides) between each disease group and the healthy group were recognized by statistical analyses. Furthermore, a two-step clustering workflow which combines multi-omics and clinical information was used to redefine molecularly and clinically differential groups. Meanwhile, molecular, clinical, network and pathway based analyses were used to identify the group-specific biological features. Results: Both shared and disease-specific molecular profiles among the six types of diseases were identified. Meanwhile, the patients were stratified into three distinct groups which were different from original disease definitions but presented significant differences in glucose and lipid metabolism (Group 1: relatively favorable metabolic conditions; Group 2: severe dyslipidemia; Group 3: dysregulated insulin and glucose). Group specific biological signatures were also systematically described. The dyslipidemia group showed higher levels in multiple lipid metabolites like phosphatidylserine and phosphatidylcholine, and showed significant up-regulations in lipid and amino acid metabolism pathways. The glucose dysregulated group showed higher levels in many polypeptides from proteins contributing to immune response. The another group, with better glucose/lipid metabolism ability, showed higher levels in lipid regulating enzymes like the lecithin cholesterol acyltransferase and proteins involved in complement and coagulation cascades. Conclusions: This multi-omics based study provides a general view of the complex relationships and an alternative classification for various metabolic diseases where the cross-talk or compensatory mechanism between the immune and metabolism systems plays a critical role.

Metabolome subtyping reveals multi-omics characteristics and biological heterogeneity in major psychiatric disorders

Dissecting Biological Heterogeneity in Major Depressive Disorder Based on Neuroimaging Subtypes with Multi-Omics Data

Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Biological Subtyping of Psychiatric Syndromes As a Pathway for Advances in Drug Discovery and Personalized Medicine

Characterizing the distinct imaging phenotypes, clinical behavior, and genetic vulnerability of brain maturational subtypes in mood disorders

Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents

Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles

A multi-omics investigation of the molecular characteristics and classification of six metabolic syndrome relevant diseases

Uncovering the genetic underpinnings for different psychiatric disorder combinations

Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders

NetMoST: A network-based machine learning approach for subtyping schizophrenia using polygenic SNP allele biomarkers

Identification of Novel Metabolic Subtypes Using Multi-Trait Limited Mixed Regression in the Chinese Population

Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder

Genetic heterogeneity and subtypes of major depression

Multi-Scale Characterization of Distance-dependent Functional Dysconnections in Major Depressive Disorder Across Two Asian Cohorts: A Genomic, Neurochemical, and Cellular Perspective

A multi-omics study of brain tissue transcription and DNA methylation revealing the genetic pathogenesis of ADHD

A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders

Integrative Analysis of Genome-Wide Association Studies Identifies Novel Loci Associated with Neuropsychiatric Disorders

Divergent patterns of genetic overlap between severe mental disorders and metabolic markers

Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder